MUKKA
Mukka Proteins Limited
Mukka Proteins Limited (MUKKA) financial statements and selected valuation metrics through 30 June 2026.
Fast Moving Consumer Goods›Fast Moving Consumer Goods›Food Products›Animal Feed
shahtaparia.com(opens the company website in a new tab)Key metrics
Price as of 2026-10-16
Full years shown; sign in free for the trailing twelve months. Learn about these metrics →
Price & valuation
Share price and valuation multiples (P/E, P/B and more) over time.
Loading price history…
Compare with peers
Loading peers…
What you need to know
Mukka Proteins turns fish into fishmeal and fish oil, sold mainly as feed for aquaculture, and is adding insect protein, organic-waste processing and frozen seafood.
Company snapshot
3rdBy market cap
Ranked among 5 companies in Animal Feed.
What we see
- ✗Over the last three years operations used more cash than they brought in, despite an operating profit — the business is not yet turning its profit into cash.
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 517 Cr | 257 Cr | 172 Cr | 149 Cr | 303 Cr | 382 Cr | 171 Cr | 245 Cr | 653 Cr | 381 Cr | 490 Cr |
| Operating expenses (approx.) | 498 Cr | 225 Cr | 158 Cr | 140 Cr | 262 Cr | 352 Cr | 156 Cr | 224 Cr | 608 Cr | 347 Cr | 442 Cr |
| EBITDA | 19 Cr | 32 Cr | 14 Cr | 10 Cr | 41 Cr | 29 Cr | 15 Cr | 21 Cr | 45 Cr | 34 Cr | 48 Cr |
| OPM % | 3.7% | 12.5% | 8.2% | 6.4% | 13.6% | 7.6% | 8.5% | 8.5% | 7.0% | 8.9% | 9.8% |
| Other income | 6 Cr | 5 Cr | 3 Cr | 3 Cr | 6 Cr | 4 Cr | 3 Cr | 6 Cr | 5 Cr | 15 Cr | 2 Cr |
| Interest | 6 Cr | 7 Cr | 8 Cr | 9 Cr | 11 Cr | 10 Cr | 11 Cr | 13 Cr | 15 Cr | 15 Cr | 16 Cr |
| Depreciation | 3 Cr | 3 Cr | 3 Cr | 4 Cr | 4 Cr | 3 Cr | 3 Cr | 4 Cr | 4 Cr | 5 Cr | 5 Cr |
| Profit before tax | 17 Cr | 27 Cr | 6 Cr | 1 Cr | 33 Cr | 20 Cr | 2 Cr | 9 Cr | 35 Cr | 29 Cr | 27 Cr |
| Tax % | 30.9% | -8.1% | 5.1% | -40.0% | 18.7% | 30.4% | 32.6% | 25.8% | 21.3% | 26.1% | 31.9% |
| Net profit | 12 Cr | 29 Cr | 5 Cr | 1 Cr | 27 Cr | 14 Cr | 2 Cr | 7 Cr | 27 Cr | 21 Cr | 19 Cr |
| EPS (₹) | ₹0.48 | ₹1.20 | ₹0.14 | ₹0.07 | ₹0.88 | ₹0.45 | ₹0.05 | ₹0.20 | ₹0.79 | ₹0.69 | ₹0.63 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 604 Cr | 771 Cr | 1,177 Cr | 1,380 Cr | 1,006 Cr | 1,449 Cr | Sign in free for the trailing twelve months |
| Operating expenses (approx.) | 582 Cr | 723 Cr | 1,091 Cr | 1,274 Cr | 912 Cr | 1,335 Cr | Sign in free for the trailing twelve months |
| EBITDA | 22 Cr | 48 Cr | 86 Cr | 105 Cr | 95 Cr | 115 Cr | Sign in free for the trailing twelve months |
| OPM % | 3.6% | 6.2% | 7.3% | 7.6% | 9.4% | 7.9% | Sign in free for the trailing twelve months |
| Other income | 6 Cr | 6 Cr | 7 Cr | 19 Cr | 15 Cr | 29 Cr | Sign in free for the trailing twelve months |
| Interest | 8 Cr | 10 Cr | 16 Cr | 25 Cr | 37 Cr | 54 Cr | Sign in free for the trailing twelve months |
| Depreciation | 8 Cr | 9 Cr | 12 Cr | 12 Cr | 14 Cr | 17 Cr | Sign in free for the trailing twelve months |
| Profit before tax | 15 Cr | 36 Cr | 66 Cr | 87 Cr | 60 Cr | 75 Cr | Sign in free for the trailing twelve months |
| Tax % | 28.8% | 28.2% | 27.9% | 15.0% | 20.2% | 24.0% | Sign in free for the trailing twelve months |
| Net profit | 11 Cr | 26 Cr | 48 Cr | 74 Cr | 48 Cr | 57 Cr | Sign in free for the trailing twelve months |
| EPS (₹) | ₹0.41 | ₹1.10 | ₹2.00 | ₹3.10 | ₹1.55 | ₹1.74 | Sign in free for the trailing twelve months |
| Dividend payout % | — | — | — | 0.0% | 0.0% | 0.0% | Sign in free for the trailing twelve months |
The latest four quarters added up, next to each full year
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Equity capital | 6 Cr | 22 Cr | 22 Cr | 30 Cr | 30 Cr | 30 Cr |
| Reserves | 60 Cr | 76 Cr | 126 Cr | 366 Cr | 411 Cr | 469 Cr |
| Borrowings | 159 Cr | 173 Cr | 255 Cr | 362 Cr | 450 Cr | 768 Cr |
| Other liabilities | 126 Cr | 116 Cr | 164 Cr | 170 Cr | 170 Cr | 325 Cr |
| Total liabilities | 354 Cr | 392 Cr | 575 Cr | 941 Cr | 1,076 Cr | 1,621 Cr |
| Fixed assets (net) | 78 Cr | 81 Cr | 83 Cr | 84 Cr | 86 Cr | 164 Cr |
| CWIP | 4 Cr | — | — | 0 Cr | 9 Cr | 30 Cr |
| Investments | 12 Cr | 21 Cr | 21 Cr | 32 Cr | 38 Cr | 57 Cr |
| Loans & advances | — | — | — | 2 Cr | 0.23 Cr | 11 Cr |
| Inventories | 150 Cr | 165 Cr | 230 Cr | 423 Cr | 564 Cr | 857 Cr |
| Trade receivables | 48 Cr | 61 Cr | 113 Cr | 185 Cr | 200 Cr | 182 Cr |
| Cash & bank | 3 Cr | 12 Cr | 27 Cr | 94 Cr | 3 Cr | 13 Cr |
| Other assets | 60 Cr | 53 Cr | 101 Cr | 120 Cr | 177 Cr | 308 Cr |
| Total assets | 354 Cr | 392 Cr | 575 Cr | 941 Cr | 1,076 Cr | 1,621 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Cash from operating activity | 6 Cr | 5 Cr | -54 Cr | -150 Cr | -112 Cr | -111 Cr |
| Cash from investing | -14 Cr | -12 Cr | -5 Cr | -48 Cr | -35 Cr | -146 Cr |
| Cash from financing | 9 Cr | 16 Cr | 75 Cr | 266 Cr | 56 Cr | 267 Cr |
| Net cash flow | 2 Cr | 8 Cr | 15 Cr | 68 Cr | -91 Cr | 10 Cr |
| Free cash flow (OCF − Capex) | -4 Cr | -1 Cr | -63 Cr | -166 Cr | -139 Cr | -232 Cr |
Ratios
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| ROCE % | 10.3% | 16.5% | 20.1% | 14.6% | 10.8% | 9.9% |
| ROE % | 13.0% | 23.5% | 28.3% | 17.2% | 10.2% | 9.8% |
| Debtor days | 29 | 29 | 35 | 49 | 72 | 46 |
| Inventory days | 99 | 92 | 83 | 116 | 224 | 218 |
| Days payable | 66 | 55 | 47 | 37 | 56 | 61 |
| Cash conversion cycle | 62 | 67 | 71 | 128 | 240 | 202 |
| OCF / EBITDA % | 27.2% | 10.1% | -63.1% | -142.6% | -118.0% | -97.1% |
| OCF / EBITDA % (3 years) | — | — | -28.0% | -83.6% | -110.5% | -118.6% |
| Debt / equity | 2.42 | 1.76 | 1.72 | 0.91 | 1.02 | 1.54 |
| Current ratio | 0.96 | 1.04 | 1.15 | 1.57 | 1.52 | 1.23 |
| Net debt / EBITDA | 7.13 | 3.40 | 2.65 | 2.54 | 4.71 | 6.59 |